104
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Rapid Detection of Ethambutol-Resistant Mycobacterium tuberculosis from Sputum by High-Resolution Melting Analysis in Beijing, China

, , , , , , , , & ORCID Icon show all
Pages 3707-3713 | Published online: 20 Oct 2020

References

  • Raviglione M, Sulis G. Tuberculosis 2015: burden, Challenges and Strategy for Control and Elimination. Infectious Disease Reports. 2016;8(2):6570. doi:10.4081/idr.2016.657027403269
  • World Health Organization. (2019) Global Tuberculosis Report 2019. 2019.
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-224650955
  • Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
  • Zhang Z, Lu J, Liu M, et al. Genotyping and molecular characteristics of multidrug-resistant. Mycobacterium Tuberculosis Isolates from China J Infect. 2015;70(4):335–345.25485999
  • Kim SJ. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J. 2005;25(3):564–569.15738303
  • Pang Y, Xia H, Zhang Z, et al. Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2013;51(6):1707–1713.23515537
  • Miotto P, Zhang Y, Cirillo DM, Yam WC. Drug resistance mechanisms and drug susceptibility testing for tuberculosis. Respirology. 2018;23(12):1098–1113.30189463
  • World Health Organization. Policy Update: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children. Geneva, Switherland: World Health Organization; 2013.
  • World Health Organization. The Use of Molecular Line Probe Assay for the Detection of Resistance to Second-Line Anti-Tuberculosis Drugs. Geneva, Switherland: World Health Organization; 2013.
  • Zhao LL, Sun Q, Liu HC, et al. Analysis of embCAB mutations associated with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates from China. Antimicrob Agents Chemother. 2015;59(4):2045–2050.25605360
  • Zhu C, Liu Y, Hu L, Yang M, He ZG. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against Mycobacterium tuberculosis. J Biol Chem. 2018;293(43):16741–16750.30185616
  • Telenti A, Philipp WJ, Sreevatsan S, et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med. 1997;3(5):567–570.9142129
  • Plinke C, Rusch-Gerdes S, Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2006;50(5):1900–1902.16641474
  • Pang Y, Dong H, Tan Y, et al. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Sci Rep. 2016;6:25330.27149911
  • Xia H, Song YY, Zhao B, et al. Multicentre evaluation of Ziehl-Neelsen and light-emitting diode fluorescence microscopy in China. Int J Tuberc Lung Dis. 2013;17(1):107–112.23232010
  • Chen Q, Pang Y, Liang Q, et al. Molecular characteristics of MDR Mycobacterium tuberculosis strains isolated in Fujian. China Tuberculosis. 2014;94(2):159–161.24325872
  • Feng Y, Liu S, Wang Q, et al. Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. PLoS One. 2013;8(2):e55292.23383320
  • Hu S, Li G, Li H, et al. Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol. 2014;52(5):1644–1652.24599986
  • Ahmad S, Jaber AA, Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis. 2007;87(2):123–129.17289435
  • Li MC, Chen R, Lin SQ, et al. Detecting Ethambutol Resistance in Mycobacterium tuberculosis Isolates in China: A Comparison Between Phenotypic Drug Susceptibility Testing Methods and DNA Sequencing of embAB. Front Microbiol. 2020;11:781.32457711
  • Zhang D, Liu B, Wang Y, Pang Y. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China. Trop Med Int Health. 2014;19(10):1259–1266.25040060
  • Plinke C, Cox HS, Kalon S, Doshetov D, Rusch-Gerdes S, Niemann S. Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis. 2009;89(6):448–452.19800845
  • Zhang Z, Wang Y, Pang Y, Kam KM. Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol. 2014;52(2):638–641.24478502
  • Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006;44(1):20–28.16390942
  • Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. Int J Tuberc Lung Dis. 2011;15(1):116–124.21276307
  • Shi D, Li L, Zhao Y, et al. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan. China J Antimicrob Chemother. 2011;66(10):2240–2247.21778195